US Patent 7329408 Eliciting HCV-specific antibodies
Patent 7329408 was granted and assigned to Novartis on February, 2008 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 1, 2000
Date of Patent
February 12, 2008
Patent Application Number
09728423
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7329408 Eliciting HCV-specific antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
